164 related articles for article (PubMed ID: 17476473)
21. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
[TBL] [Abstract][Full Text] [Related]
22. Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts.
Sakaguchi M; Miyazaki M; Inoue Y; Tsuji T; Kouchi H; Tanaka T; Yamada H; Namba M
J Cell Biol; 2000 Jun; 149(6):1193-206. PubMed ID: 10851017
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.
Park Y; Kim W; Lee JM; Park J; Cho JK; Pang K; Lee J; Kim D; Park SW; Yang KM; Kim SJ
Oncogene; 2015 Sep; 34(39):5037-45. PubMed ID: 25531329
[TBL] [Abstract][Full Text] [Related]
24. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
25. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation.
Descargues P; Sil AK; Sano Y; Korchynskyi O; Han G; Owens P; Wang XJ; Karin M
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2487-92. PubMed ID: 18268325
[TBL] [Abstract][Full Text] [Related]
26. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
27. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
[TBL] [Abstract][Full Text] [Related]
29. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
30. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells.
Jakus J; Yeudall WA
Oncogene; 1996 Jun; 12(11):2369-76. PubMed ID: 8649777
[TBL] [Abstract][Full Text] [Related]
32. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma.
Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S
Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730
[TBL] [Abstract][Full Text] [Related]
34. PIAS1-modulated Smad2/4 complex activation is involved in zinc-induced cancer cell apoptosis.
Yang N; Zhao B; Rasul A; Qin H; Li J; Li X
Cell Death Dis; 2013 Sep; 4(9):e811. PubMed ID: 24052079
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
[TBL] [Abstract][Full Text] [Related]
36. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta.
Major MB; Jones DA
J Biol Chem; 2004 Feb; 279(7):5278-87. PubMed ID: 14630914
[TBL] [Abstract][Full Text] [Related]
37. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
38. TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression.
Voss M; Wolff B; Savitskaia N; Ungefroren H; Deppert W; Schmiegel W; Kalthoff H; Naumann M
Int J Oncol; 1999 Jan; 14(1):93-101. PubMed ID: 9863014
[TBL] [Abstract][Full Text] [Related]
39. Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Vijayachandra K; Higgins W; Lee J; Glick A
Mol Carcinog; 2009 Mar; 48(3):181-186. PubMed ID: 18655107
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
